Goede V, Fischer K, Dyer MJS, et al. Overall survival benefit of obinutuzumab over rituximab when combined with chlorambucil in patients with chronic lymphocytic leukemia and comorbidities: final survival analysis of the CLL11 study. EHA 2018; abstract S151.
Primaire auto-immuun hemolytische anemie geassocieerd met ischemisch CVA
feb 2024 | Benigne hematologie, Neuro-vasculair